Korean Drug Co., Ltd. (KOSDAQ:014570)

Korean Drug Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,848	4,103	11,689	3,426	4,841	7,068
Short-Term Investments	19,904	14,897	5,067	22,990	-	-
Trading Asset Securities	-	-	-	-	23,039	15,162
Cash & Short-Term Investments	25,753	19,000	16,756	26,416	27,881	22,230
Cash Growth	48.84%	13.39%	-36.57%	-5.25%	25.42%	92.87%
Accounts Receivable	18,414	22,813	27,854	31,196	28,501	27,880
Other Receivables	14.24	77.99	154.04	264.21	481.69	13.67
Receivables	18,428	22,891	28,008	31,460	28,983	27,894
Inventory	20,529	20,168	18,341	13,775	12,894	10,744
Prepaid Expenses	-	26.21	29.68	15.8	14.88	12.11
Other Current Assets	1,311	841.25	291.26	949.19	677.81	2,075
Total Current Assets	66,020	62,925	63,426	72,617	70,450	62,956
Property, Plant & Equipment	21,694	22,054	22,999	18,607	13,999	13,784
Long-Term Investments	219.79	331.39	261.49	363.89	1,353	2,610
Other Intangible Assets	212.87	208.92	362.8	490.55	263.02	672.79
Long-Term Accounts Receivable	-0	-0	-	-	-	-
Long-Term Deferred Tax Assets	1,172	1,208	1,015	1,163	820.32	307.16
Other Long-Term Assets	1,574	2,159	1,645	1,276	1,728	3,015
Total Assets	90,894	88,887	89,709	94,516	88,613	83,345
Accounts Payable	2,816	570.28	1,921	4.55	3,213	2,662
Accrued Expenses	1,686	1,820	1,951	1,896	1,131	974.24
Current Portion of Leases	60.09	63.05	51.31	59.47	39.07	45.85
Current Income Taxes Payable	361.59	442.95	2,192	1,499	2,151	1,788
Other Current Liabilities	5,341	4,314	3,786	3,953	3,796	4,301
Total Current Liabilities	10,264	7,210	9,902	7,412	10,329	9,771
Long-Term Leases	8.14	17.91	16.26	21.73	15	6.16
Other Long-Term Liabilities	3,459	3,553	2,355	2,107	1,579	2,697
Total Liabilities	13,732	10,781	12,619	9,804	11,923	12,474
Common Stock	5,500	5,500	5,500	5,500	5,500	5,500
Additional Paid-In Capital	3,370	3,375	3,430	3,431	3,430	3,419
Retained Earnings	69,636	70,591	69,724	77,364	69,345	62,488
Treasury Stock	-1,344	-1,360	-1,563	-1,583	-1,586	-536.16
Comprehensive Income & Other	-0	-0	-0	-0	0	0
Shareholders' Equity	77,162	78,106	77,090	84,713	76,690	70,871
Total Liabilities & Equity	90,894	88,887	89,709	94,516	88,613	83,345
Total Debt	68.23	80.97	67.57	81.2	54.07	52.01
Net Cash (Debt)	25,685	18,919	16,688	26,335	27,826	22,178
Net Cash Growth	48.99%	13.37%	-36.63%	-5.36%	25.47%	93.77%
Net Cash Per Share	2388.66	1753.14	1547.64	2442.18	2546.94	2041.29
Filing Date Shares Outstanding	10.82	10.81	10.79	10.78	10.78	10.89
Total Common Shares Outstanding	10.82	10.81	10.79	10.78	10.78	10.89
Working Capital	55,756	55,715	53,524	65,205	60,121	53,184
Book Value Per Share	7133.53	7222.25	7146.81	7855.42	7111.75	6507.00
Tangible Book Value	76,949	77,897	76,727	84,222	76,427	70,198
Tangible Book Value Per Share	7113.85	7202.93	7113.17	7809.93	7087.35	6445.23
Land	7,494	7,494	7,681	7,681	5,748	5,748
Buildings	6,788	14,955	14,955	11,264	11,264	11,006
Machinery	6,234	11,639	9,974	7,215	7,387	6,845
Construction In Progress	67.55	-	969.41	3,376	-	3.6

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.